Clinical Trial Update: A Phase I Study of Taxol, Cisplatin, Cyclophosphamide and Granulocyte Colony-Stimulating Factor (G-CSF) in Previously Nontreated Ovarian Cancer Patients [Phase 1]

View source ↗

Summary

Phase I study evaluating a four-drug regimen of paclitaxel (Taxol), cisplatin, cyclophosphamide, and G-CSF in previously untreated ovarian cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Granulocyte Colony Stimulating Factor (granulocyte colony-stimulating factor (G-CSF))
• Paclitaxel (Taxol) (paclitaxel)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Ovarian Neoplasms | Phase 1 | Status: COMPLETED